Major public hospitals had the right of first refusal in taking on the additional 11 th Project
HCSs were grown in media supplemented with 20 ng/mL of bFGF (Shenandoah Biotechnologies/VWR, Cat# 10821-972) and epidermal growth factor (EGF) (Shenandoah Biotechnologies/VWR, Cat# 10787-462) from days 625, and 20 ng/mL of Brain Derived Neurotropic Factor (Shenandoah Biotechnologies/VWR, Cat# 10788-816) and Neurotrophin-3 (Shenandoah Biotechnologies, Cat# 800-06-100ug) from days 2642 with media replaced every other day
In addition, due to the poor solubility of Qu in water, it cannot be fully dissolved in the dermis even loaded in normal MSN or other nanoparticles [34,35], so traditional nano-delivery of Qu may not significantly increase the therapeutic effect on AGA [36]
Formulation: Lyophilized peptide intended for reconstitution with appropriate sterile diluent (for vial products) or encapsulated powder for oral research formats, all designated for research use only
.webp)
